# Bioequivalence Study of Levomerc 500 mg Tablets

> **NCT05339295** · PHASE1 · COMPLETED · sponsor: **University of Karachi** · enrollment: 24 (actual)

## Conditions studied

- Healthy
- Pharmacokintetics

## Interventions

- **DRUG:** Levofloxacin 500mg

## Key facts

- **NCT ID:** NCT05339295
- **Lead sponsor:** University of Karachi
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-11
- **Primary completion:** 2012-07-20
- **Final completion:** 2012-09-20
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-09-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05339295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05339295, "Bioequivalence Study of Levomerc 500 mg Tablets". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05339295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*